NEW PATHWAYS TO SMARTER MEDICINETM


Bringing hope to millions of patients by creating new medicines that treat serious medical needs. More

Optimizing therapeutic benefit with our unparalleled expertise in polymer chemistry. More

Advancing the treatment of autoimmune disorders, chronic inflammatory conditions and cancer with novel therapies which selectively modulate the immune system. More

Discover Our approach

Restoring the immune system balance with T regulatory cells – Interview with Dr Christie Fanton

WATCH

Explore the role of the interleukin-15 (IL-15) pathway in immune response.

WATCH

Events

  • Jan 08

    J.P. Morgan 2024 Healthcare Conference

    San Francisco, CA

    5:15 PM PT

    Listen to Webcast

    Download Presentation

  • Nov 07

    Q3 2023 Financial Results

    Virtual

    5:00 PM EDT

    Listen to Webcast

  • Aug 08

    Q2 2023 Financial Results

    Virtual

    2:00 PM, PT

    Listen to Webcast

Latest News

Content placeholder

    OUR PIPELINE

    We are focused on creating novel therapies aimed at selectively modulating the immune system to advance the treatment of autoimmune disorders, chronic inflammatory conditions and cancer.

    • 9

      Million patients benefit from our medicines

    • 12

      Approved products around the world

    • 6

      R&D Pipeline Programs

    Join Nektar Team

    Join Our Team

    Find out what it’s like to be part of a dynamic team full of diverse perspectives and unique ideas, brought together by expertise and a passion for making a difference for patients with unmet medical needs.

    Read More